Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The Publications note was updated to indicate that PubMed auto-filled publications may not be about the study, and the revision label was updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:01:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The study details page appears unchanged between versions; no new content or deletions are evident in the screenshots. The overall layout and information remain the same.
    Difference
    0.5%
    Check dated 2025-11-03T21:01:36.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:48.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Updated software version from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:15.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (up from v3.0.1). The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:05:15.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.